kilat 333KT-333 is the first heterobifunctional degrader against an undrugged transcription factor to enter clinical development. In November 2021, Kymera announced that multiple abstracts wereKilat33 adalah platform seru yang bikin lo gak bisa berhenti karena tiap main selalu ada aja kesempatan menang yang gampang banget